logo

For the Inventor, By the Inventor

Lund, Sweden

Bioinvent International Ab

USPTO Granted Patents = 19

% Expired Patents = 21.1



Trademarks = 3

Forward Citations = 528

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Björn Frendéus (8 out of 14 patents)

silverMedal Ingrid Teige (5 out of 12 patents)

bronzeMedal Linda Mårtensson (5 out of 7 patents)

4.  Carl A Borrebaeck (5 out of 5 patents)

5.  Roland Carlsson (4 out of 13 patents)

6.  Carl Arne Krister Borrebaeck (3 out of 13 patents)

7.  Ulf Hans Eskil Soderlind (3 out of 4 patents)

8.  Petra Holmkvist (3 out of 3 patents)

9.  Monika Semmrich (3 out of 4 patents)

10.  Mark Steven Cragg (1 out of 8 patents)

11.  Reimar Abraham (1 out of 7 patents)

12.  Jan Nilsson (1 out of 23 patents)

13.  Mauricio Redondo-Müller (1 out of 2 patents)

14.  Ali Roghanian (1 out of 5 patents)

15.  Jenny Mattsson (1 out of 1 patent)


19 patents:

1. 12441805 - Antagonistic anti-TNFR2 antibodies (2025-10-14),
2. 12344673 - Medicaments, uses and methods (2025-07-01),
3. 12291569 - Antibodies and nucleotide sequences, and uses thereof (2025-05-06),
4. 12139547 - Agonistic anti TNFR2 antibody molecules (2024-11-12),
5. 11648310 - Combination of anti-FGFR4-antibody and bile acid sequestrant (2023-05-16),
6. 10351970 - Method for screening anti-ligand libraries for identifying anti-ligands specific for differentially and infrequently expressed ligands (2019-07-16),
7. 10191049 - Screening methods and uses thereof (2019-01-29),
8. 9803013 - Biological materials and uses thereof (2017-10-31),
9. 8758749 - Biological materials and uses thereof (2014-06-24),
10. 7943744 - ICAM-1 binding antibodies (2011-05-17),
11. 7521046 - Antibody immunization therapy for treatment of atherosclerosis (2009-04-21),
12. 7432083 - Method for in vitro molecular evolution of protein function (2008-10-07),
13. 6989250 - Method for in vitro molecular evolution of protein function (2006-01-24),
14. 6607881 - Combined ligand and receptor display (2003-08-19),
15. 6495321 - Method for in vitro molecular evolution of protein function (2002-12-17),
Company Overview
Bioinvent International AB, based in Lund, Sweden, is a biotechnology company focused on the development of innovative antibody-based therapies for the treatment of cancer and other serious diseases. The company specializes in the discovery and development of monoclonal antibodies, leveraging its proprietary technology platforms to create novel therapeutic candidates. Bioinvent's research emphasizes the importance of targeting specific disease mechanisms, aiming to improve patient outcomes through advanced biopharmaceutical solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#25 in Lund

#345 in Sweden

#32,693 in the World

Lund, SE
Lund, Sweden

Bioinvent International Ab

Forward Citations = 528

27 inventors:

goldMedal Björn Frendéus (8 out of 14 patents)

silverMedal Ingrid Teige (5 out of 12 patents)

bronzeMedal Linda Mårtensson (5 out of 7 patents)

4.  Carl A Borrebaeck (5 out of 5 patents)

5.  Roland Carlsson (4 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioinvent International Ab. Retrieved from https://idiyas.com/company/bioinvent-international-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…